Skip to Main Content

Paper Details

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.
N Engl J Med
872
2016
CD8+, CD8+ T-cell, CD8+ cells, Cancer, G12D, HLA-C*08:, HLA-C*08:02, HLA-C*08:02 class I major histocompatibility complex, HLA-C*08:02-restricted tumor-infiltrating lymphocytes, KRAS, KRAS G12D, MHC, Mutant KRAS, T, T-cell clonotypes, cancer, chromosome 6 haplotype, lung metastases, metastatic colorectal cancer, mutant KRAS, mutant KRAS G12D, patient, tumor, tumor-infiltrating lymphocytes
Author NameAffiliation
Todd D PrickettNational Cancer Institute, National Institutes of Health
Todd D PrickettNational Cancer Institute, National Institutes of Health
Jared J GartnerNational Cancer Institute, National Institutes of Health
Jared J GartnerNational Cancer Institute, National Institutes of Health
Satyajit RayNational Cancer Institute, National Institutes of Health
Satyajit RayNational Cancer Institute, National Institutes of Health
Steven A RosenbergNational Cancer Institute, National Institutes of Health
Steven A RosenbergNational Cancer Institute, National Institutes of Health
  • 1 - 8

Datasets

Release 1.2